Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPAYA: PK of 4000L Alglucosidase Alfa in Pompe Disease
NCT01410890Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2014
- Primary completion
- Nov 2020
- Modality
- Replacement Enzymes
- Countries
- 6
01
Overview
A Phase 4 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Nov 2014; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT01410890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410890.